 |
 |
In addition to an abstract of the British Medical Journal article pointing out the increased mortality with Eldepryl, there is an article on the Parkinson's Web (http://neuro-chief-e.mgh.harvard.edu/parkinsonsweb/main/pdmain.html) entitled Deprenyl - a 1994 Update. The article predates that in the BMJ and includes one line worth mentioning: ".....the addition of selegiline to levodopa therapy in PD patients also lengthened their lifetime". Seems that you pick your reading material and make your choices. ;>) or :>(